St Jude Medical received european Approval of ICDs with Features That Automatically Enhance Patient

St. Jude Medical received european Approval of ICDs  with Features That Automatically Enhance Patient Safety

St. Jude Medical, Inc.announced European CE Mark approval of its AnalyST Accel and Current Accel™ ICDs, which automatically adjust therapy to changing patient needs for increased safety and accelerated follow-up.

The St. Jude Medical Accel family of ICD devices can be programmed to automatically monitor and adjust the level of electrical energy needed for stimulating the patient’s heart, which helps to ensure that adequate therapy is consistently administered while conserving battery life. The devices do this by measuring the heart’s reaction to electrical stimulation from the device and confirming that the heart is responding to the stimulation.

To better assist physicians in accurately diagnosing and managing patients with fast rates in the heart’s upper chambers (atria), the devices also include a new AT/AF Alert feature. This feature is designed to notify physicians when a rapid atrial rate (atrial tachycardia/atrial fibrillation [AT/AF]) exceeds a programmed value or occurs over an extended time period.